TY  - CONF

T1  - MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J

JO  - Journal of Thoracic Oncology

UR  - http://dx.doi.org/10.1016/j.jtho.2023.09.154

PY  - 2023/11/01

AU  - Middleton G

AU  - Fletcher P

AU  - Savage J

AU  - Mehmi M

AU  - Greystoke A

AU  - Dangoor A

AU  - Cave J

AU  - Escriu C

AU  - Shaw P

AU  - Steele N

AU  - Jain P et al

ED  - 

DO  - DOI: 10.1016/j.jtho.2023.09.154

PB  - Elsevier BV

VL  - 18

IS  - 11

SP  - S119

EP  - S120

Y2  - 2024/09/19

ER  -